当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › EMBO Molecular Medicine杂志
EMBO Molecular Medicine
基本信息
期刊名称 EMBO Molecular Medicine
EMBO MOL MED
期刊ISSN 1757-4676
期刊官方网站 https://www.embopress.org/journal/17574684
是否OA Yes
出版商 Springer
出版周期 Monthly
文章处理费 登录后查看
始发年份 2009
年文章数 112
影响因子 9.0(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 17.7 3.964 1.787
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
12/178 93%
补充信息
自引率 1.1%
H-index 90
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1757-4676%5BISSN%5D
投稿指南
期刊投稿网址 http://embomolmed.msubmit.net/cgi-bin/main.plex
收稿范围
EMBO Molecular Medicine is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance.

To enhance and better specify our commitment to precision medicine, we have expanded the scope of EMM and call for contributions in the following fields:

Environmental health and medicine, in particular studies in the field of environmental medicine in its functional and mechanistic aspects (exposome studies, toxicology, biomarkers, modeling, and intervention).
Clinical studies and case reports - Human clinical studies providing decisive clues how to control a given disease (epidemiological, pathophysiological, therapeutic, and vaccine studies). Case reports supporting hypothesis-driven research on the disease.
Biomedical technologies - Studies that present innovative materials, tools, devices, and technologies with direct translational potential and applicability (imaging technologies, drug delivery systems, tissue engineering, and AI)
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Philippe Sansonetti (Chief Editor)

(Institut Pasteur, Paris)

 

Philippe Sansonetti trained as a medical doctor at the Université Paris VI, France before moving into research. In 1989 he founded and became the director of the Insitut Pasteur’s Molecular Microbial Pathogenesis Unit. He is Professor of Microbiology and Infectious Diseases at the Collège de France. He has acted as Medical Director of the Institut Pasteur hospital, and held administrative positions at INSERM, the French Ministry of Research and Technology and the World Health Organisation.

 

Sansonetti’s research focuses on the molecular pathogenesis of bacterial infections. He has contributed detailed understanding of the molecular mechanisms through which Shigella invades and kills cells, and is developing vaccine candidates against this dysentery-causing bacterium.

 

His work has been recognized by numerous awards and he is an elected member of national and international organisations, including EMBO, the French Academy of Sciences, The Royal Society and the US National Academy of Sciences.

 

editor@embomolmed.org

 

       Céline Carret (Senior Scientific Editor)

Responsible for: neuroscience, genetic disease, mitochondrial diseases, myopathies, stem cells, regenerative medicine, gene therapy, host-pathogen interactions, innate immunity and vaccinology, aging, skin disorders

 

Céline Carret completed her PhD at the University of Montpellier, France, characterising host immunodominant antigens to fight babesiosis, a parasitic disease caused by a unicellular Apicomplexan parasite closely related to the malaria agent Plasmodium. She further developed her post-doctoral career on malaria working at the Wellcome Trust Sanger Institute in Cambridge, UK and Instituto de Medicina Molecular in Lisbon, Portugal. Céline joined EMBO Molecular Medicine as a Scientific Editor in March 2011.

/pb-assets/embo-site/images/headshots/

c.carret@embomolmed.org

tel: +49 6221 8891 411

 

       Lise Roth (Scientific Editor)

Responsible for: cancer, cancer stem cells, immunotherapy, immune disorders, metabolism, obesity and diabetes, angiogenesis, cardiovascular diseases, respiratory diseases, asthma

 

Lise Roth received her PhD in 2008 from the University of Strasbourg, France, where she studied the role of the transmembrane domain of NRP1 in Sema3A and VEGF signaling. She carried out post-doctoral research on tumor-targeting peptides in Sanford Burnham Prebys Medical Discovery Institute, Santa Barbara, USA, and in 2011, joined the German Cancer Research Center (DKFZ), where she focused on NRP1-mediated vascular permeability and on the role of Tie1 in tumor angiogenesis and metastasis. Lise joined EMBO Molecular Medicine as a Scientific Editor in January 2018.

 

l.roth@embomolmed.org

tel: +49 6221 8891 412

 

       Jingyi Hou (Scientific Editor)

Responsible for: biomarkers and diagnostics, genomics, proteomics, metabolomics, and systems medicine

 

Jingyi Hou received her PhD from the Free University Berlin / Max-Delbrück Center for Molecular Medicine, where she dissected cis-regulatory mechanisms that control mRNA translation using various mouse models. As a post-doc, she joined the laboratory of Erin O’Shea at the HHMI - Janelia Research Campus in USA, where she focused on the role of RNA methylation in the nervous system development and in learning and memory formation. Jingyi joined EMBO Molecular Medicine as a Scientific Editor in November 2018.

 

j.hou@embomolmed.org

tel: +49 6221 8891 116

 

JOURNAL STAFF

From left: Annika Diederich (Editorial Assistant), Christopher Rickerby (Editorial Assistant), Erica Wilfong Boxheimer (Data Integrity Analyst), Fiona Panayi (Editorial Administrator), Joel Maupin (Marketing and Project Manager)

 

 

 

WILEY EDITORIAL STAFF

Cate Livingstone   - Executive Editor, Global Research, Wiley

Georgi Hristov      - Assistant Editor, EMBO Press

Vivian Killet    - Assistant Editor, EMBO Press

Uta Mackensen     - Graphics Editor

SENIOR EDITORS

       Dario Alessi (MRC, Dundee)

 

d.r.alessi@dundee.ac.uk

 

Dario Alessi discovered PDK1, a master regulator of insulin-controlled responses and a key anti-cancer agent. His group has also identified a key activatory link between LKB1 and AMPK that impacts on LKB1's activity as tumour-suppressor and as activator for a number of other genes, some of which have been associated with Alzheimer's disease.

       Giulio Cossu (Institute of Inflammation and Repair, University of Manchester, Manchester)

 

giulio.cossu@manchester.ac.uk

 

Giulio Cossu's interests are in the pathophysiology of muscle development. His group has been working for a number of years on the signals and mechanism that regulate the formation of skeletal muscle during embryonic development and, after birth, when the muscle tissue is damaged as a result of an injury or a primary myopathy.

       Stefanie Dimmeler (Goethe University, Frankfurt)

 

dimmeler@em.uni-frankfurt.de

 

Stefanie Dimmeler is Professor of Experimental Medicine and Director of the Institute of Cardiovascular Regeneration, Center for Molecular Medicine at the University of Frankfurt, Germany. Her group elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Her current ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and microRNAs. She received several international prizes including the Leibniz Award 2005, the Award of the Jung Foundation 2007 and the FEBS award in 2006.

       Uta Francke (Stanford School of Medicine, Stanford)

 

ufrancke@stanford.edu

 

Uta Francke's research interests are to understand the functional consequences of microdeletions that cause defined clinical syndromes. Her laboratory has created mouse models for Williams-Beuren syndrome and Prader-Willi syndrome (PWS). The PWS mice are deleted for an imprinted cluster of C/D box small nucleolar RNA (snoRNA) genes. Current goals are to identify the function of these snoRNAs and to understand how their loss causes the PWS phenotype.

       Fred Gage (Salk Institute, San Diego)

 

gage@salk.edu

 

Fred Gage concentrates on the adult central nervous system and the plasticity and adaptability to environmental stimulation that remains throughout the life of all mammals. His work may open up the possibility for replacement of brain tissue lost to stroke or Alzheimer's disease and repairing spinal cords damaged by trauma.

       Matthias Hentze (EMBL, Heidelberg)

 

hentze@embl.de

 

Matthias Hentze's main research interests are the regulation of translation by RNA-binding proteins and microRNAs and the impact that errors in RNA processing and translation have on the ontogeny, progression, diagnosis and therapeutics of human disease. Matthias Hentze is a strong proponent of the concept of "from bench to bedside - and back".

       Gökhan S. Hotamışlıgil (Harvard University School of Public Health, Boston)

 

ghotamis@hsph.harvard.edu

 

Gökhan Hotamışlıgil is the James S. Simmons Professor of Genetics & Metabolism and Chair of the Department of Genetics & Complex Diseases at the Harvard University School of Public Health. His research centres on the molecular mechanisms of integration between nutrient and pathogen sensing and response pathways in metabolic homeostasis, the metabolic functions of the endoplasmic reticulum, and molecules that govern the biological functions of lipids. Gökhan Hotamışlıgil's contributions have led to the emerging field of "immunometabolism" and produced novel translational avenues against chronic metabolic diseases.

       Joan Massagué (Memorial Sloan-Kettering Cancer Center, New York)

 

j-massague@ski.mskcc.org

 

Joan Massagué received his Ph.D. degree from the University of Barcelona. He then joined the faculty at the University of Massachusetts Medical School and was later appointed Chair of Cancer Biology, Memorial Sloan-Kettering Cancer Center. He is currently Director of the Sloan-Kettering Institute. His main contributions include the identification of the TGFβ receptors and signal transducers, and the central concept of how this pathway controls cell proliferation and differentiation. Recently, he defined genes and mechanisms for cancer cell dissemination and metastasis. Joan Massagué is an elected member of the U.S. National Academy of Sciences, the Institute of Medicine, and EMBO.

       Bart de Strooper (Dept of Mol. & Dev. Genetics, KU Leuven)

 

Bart.Destrooper@med.kuleuven.be

 

Bart de Strooper's research interests are the cell biology of Alzheimer's Disease and Parkinson's Disease. He demonstrated the central role of Presenilin in γ-Secretase processing of Amyloid Precursor Protein and Notch. He received several international prices including the Potamkin Prize in 2002, the Alois Alzheimer Award in 2004 and the Metlife Award in 2008.

EMBO Molecular Medicine

Meyerhofstrasse 1

D-69117 Heidelberg, Germany

Phone: +49 6221 8891 310

Fax: +49 6221 8891 240

info@embomolmed.org

 

ADVISORY EDITORIAL BOARD

Adriano Aguzzi, Zürich

Kari Alitalo, Helsinki

Stylianos Antonarakis, Geneva

Alan Ashworth, London

Hellmut Augustin, Heidelberg

Alberto Auricchio, Italy

Karen B. Avraham, Tel Aviv

Andrea Ballabio, Napoli

Yann Barrandon, Lausanne

Eduard Batlle, Barceona

Anton J. Berns, Amsterdam

Cédric Blanpain, Brussels

Clara D. Bloomfield, Columbus

Carlos Caldas, Cambridge

Vivian Cheung, Philadelphia

Kenneth Chien, Stockholm

Hans Clevers, Utrecht

Ralph DeBerardinis, Dallas

Elisabetta Dejana, Milano

Sven Diederichs, Freiburg

Oliver Eickelberg, Munich

Martin Eilers, Marburg

Marc Feldmann, London

Alain Fischer, Paris

Philippe Froguel, London

Gerardo Gamba, Mexico City

Bart Lambrecht, Ghent

Martin Gleave, Vancouver

Christian Haass, München

Carl-Henrik Heldin, Uppsala

Jan Hoeijmakers, Rotterdam

Nancy E. Hynes, Basel

Alain Israel, Paris

Barbara B. Kahn, Boston

Gerard Karsenty, New York

Cynthia Kenyon, San Francisco

Robert S. Kerbel, Toronto

Jean-Pierre Kinet, Boston

Andreas E. Kulozik, Heidelberg

Guido Kroemer, Paris

Claude Libert, Ghent

Salvador Moncada, London

Matthias Nahrendorf, Boston

Luigi Naldini, Milan

Mihai Netea, Nijmegen

Pierluigi Nicotera, Bonn

Bernd Nilius, Leuven

Eric N. Olson, Dallas

Stephen O'Rahilly, Cambridge

Albert Osterhaus, Rotterdam

Manolis Pasparakis, Köln

Christine Petit, Paris

Kornelia Polyak, Boston

Rino Rappuoli, Siena

Peter J. Ratcliffe, Oxford

Gideon Rechavi, Tel Aviv

Paola Ricciardi-Castagnoli, Singapore

Nadia Rosenthal, Monterotondo

Maria Rescigno, Milan

Owen Sansom, Glasgow

Nicholas J. Schork, La Jolla

Yosef Shiloh, Ramat Aviv

Gerald Shulman, New Haven

Bruce Spiegelman, Boston

Deepak Srivastava, San Francisco

Anu Suomalainen-Wartiovaara, Helsinki

Giulio Superti-Furga, Vienna

Elaine I. Tuomanen, Memphis

Axel Ullrich, Martinsried

Simon Wain-Hobson, Paris

Gerd Walz, Freiburg

Fiona Watt, London

Christian Weber, München

Lars Zender, Tuebingen

Massimo Zeviani, Cambridge


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug